Lawsuits

Georgia Jury Awards $2 Billion for Cancer Claim Against Bayer; State Considers Law to Limit Future Lawsuits

by

DALTON, Ga. — A monumental $2 billion jury award to a Georgia man who attributes his cancer to prolonged Roundup herbicide use has garnered significant attention, coinciding with a proposed state law that might prevent such cases from reaching court in the future. The verdict has notably impacted Bayer AG, the parent company of Monsanto, which developed Roundup. Georgia resident John Barnes, who has battled non-Hodgkin lymphoma (NHL), claimed his illness was due to using Roundup from 1999 to 2019. The jury awarded Barnes, a former Marine and family man, $2 billion in punitive damages … Read more

Bankrupt Houston Law Firm Partners With Litigation Funders to Salvage Proceeds from Ongoing Lawsuits

by

Houston, Texas — The financially embattled MMA Law Firm PLLC, based in Houston, has entered into a significant agreement with one of its principal creditors, Equal Access Justice Fund LP. Under the new arrangement, the law firm will share the revenue from its collection of mass tort lawsuits. MMA Law Firm, which recently declared bankruptcy, sees this partnership as a strategic move to stabilize its financial standing while still actively pursuing justice in its large-scale legal cases. These cases typically involve claims against corporations for damages that affect large groups of people. Under the terms … Read more

Judge Sets Challenging Precedents for Ozempic Lawsuits Regarding Side Effects

by

A recent court order presents significant challenges for individuals seeking to sue the manufacturers of Ozempic, a popular diabetes medication, over alleged adverse side effects. The ruling, issued in San Francisco, complicates the process for plaintiffs to bring their cases against the pharmaceutical giant, Novo Nordisk. The court’s determination focused on procedural aspects that could limit the breadth of claims that plaintiffs can consolidate into a single class-action lawsuit. This decision inherently stresses the necessity for plaintiffs to possibly pursue their grievances individually, a route that could diminish their negotiating power and increase legal expenses. … Read more

Courts Dismiss 100 Decongestant Lawsuits Over Alleged Fake Ingredient Claims

by

In a growing legal turmoil, approximately 100 lawsuits have been filed across the United States challenging the efficiency of a common ingredient in over-the-counter decongestants. Plaintiffs claim that phenylephrine, the active ingredient in many nasal decongestants, is ineffective at relieving nasal congestion when taken orally in the 10 mg dosage found in common products. Despite being approved by the Food and Drug Administration as a replacement for pseudoephedrine, consumer reports and scientific studies have recently brought to light concerns about phenylephrine’s efficacy. The adjustment in active ingredients was primarily due to regulatory measures aimed at … Read more